comparemela.com

Page 8 - Nordic Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

New MRII President elected for 2021/22

New MRII President elected for 2021/22
imt.ie - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from imt.ie Daily Mail and Mail on Sunday newspapers.

New MRII President elected for 2021/2022

New MRII President elected for 2021/2022 The newly elected President of Healthcare Industry Representatives in Ireland (MRII) for 2021/2022 has been announced as Olive Kelly, Key Account Manager with Nordic Pharma Ireland. Olive Kelly, new MRII President The MRII is a not-for-profit organisation, the educational body for healthcare industry representatives in Ireland with 400 members. The Institute works on behalf of their members to provide educational and development opportunities for those working in customer-facing roles within pharmaceutical and medical device companies in Ireland. “As healthcare industry representatives, MRII members have seen first-hand how challenging the pandemic has been for Irish healthcare professionals working on the front line. They remain available as industry representatives to provide expert knowledge on medicines and products and to support our healthcare professionals,” according to the MRII.

Amring Pharmaceuticals Inc Enters into License and Development Agreement with Amzell B V

Press release content from Business Wire. The AP news staff was not involved in its creation. Amring Pharmaceuticals Inc. Enters into License and Development Agreement with Amzell B.V. March 12, 2021 GMT BERWYN, Pa. (BUSINESS WIRE) Mar 12, 2021 Amring Pharmaceuticals Inc. (Amring), a niche brand and generic pharmaceutical company, announced today an agreement with Amzell B.V. (Amzell) that will further strengthen its position in the marketplace with the commercial rights to one of Amzell’s leading clinical-stage programs that will bring a critical and accessible therapy for patients in need. Under this agreement Amzell will complete the full clinical development of the product in specific markets and Amring will commercialize the product. Amring will invest an undisclosed amount in the development through the clinical phase and FDA approval process.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.